Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double ‐blind, placebo‐controlled study

ConclusionAn 8‐week course of treatment with cilostazol as an adjunct to risperidone showed a favorable safety and efficacy profile in patients with schizophrenia.

Source: Human Psychopharmacology: Clinical and Experimental - March 1, 2017 Category: Psychiatry Authors: Farzin Rezaei, Bita Mesgarpour, Alireza Jeddian, Atefeh Zeionoddini, Payam Mohammadinejad, Elaheh Salardini, Mona Shahriari, Arefeh Zeinoddini, Shahin Akhondzadeh Tags: RESEARCH ARTICLE Source Type: research